MRC1 and neoplasm: Mice receiving anti-IFNAR1 antibody showed a significant increase in PD-1 expressing tumor-infiltrated CD4+ and CD8+ T cells (Figure 6E) and a significant increase in tumor-infiltrating M2-like macrophages (CD206+ F4/80+), compared to the isotype control treated group (Figure 6F).